A number of other analysts have also recently weighed in on CWC. Analysts at BNP Paribas reiterated an “underperform” rating on shares of Cable & Wireless Communications in a research note to investors on Monday. They now have a GBX 39 ($0.61) price target on the stock. Separately, analysts at AlphaValue reiterated a “buy” rating on shares of Cable & Wireless Communications in a research note to investors on Thursday, June 13th. They now have a GBX 53 ($0.83) price target on the stock. Finally, analysts at Morgan Stanley reiterated an “equal weight” rating on shares of Cable & Wireless Communications in a research note to investors on Monday, June 10th. They now have a GBX 47 ($0.74) price target on the stock.

Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of GBX 45.47 ($0.71).

Shares of Cable & Wireless Communications (LON: CWC) opened at 41.69 on Wednesday. Cable & Wireless Communications has a 52 week low of GBX 28.19 and a 52 week high of GBX 46.53. The stock’s 50-day moving average is currently GBX 35.68. The company’s market cap is £1.041 billion.

Cable & Wireless Communications Plc is an international telecommunications service provider. It operates integrated telecommunications companies offering mobile, broadband, television (LON: CWC) and fixed line and enterprise services to residential and business customers.

Spirent Communications (LON: SPT) opened at 132.00 on Wednesday. Spirent Communications has a 52-week low of GBX 106.20 and a 52-week high of GBX 172.10. The stock’s 50-day moving average is currently GBX 158.5. The company’s market cap is £855.4 million.

Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Spirent Communications in a research note to investors on Tuesday. They now have a GBX 125 ($1.96) price target on the stock. Separately, analysts at Panmure Gordon reiterated a “buy” rating on shares of Spirent Communications in a research note to investors on Monday. They now have a GBX 176 ($2.76) price target on the stock. Finally, analysts at Panmure Gordon cut their price target on shares of Spirent Communications from GBX 181 ($2.84) to GBX 176 ($2.76) in a research note to investors on Friday, June 7th. They now have a “buy” rating on the stock.

Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of GBX 155.15 ($2.44).

Spirent Communications plc operates in the communications test and measurement industry. The Company is organized into three business segments: Performance Analysis, Service Assurance and Systems.

Several analysts have recently commented on the stock. Analysts at Thomson Reuters/Verus upgraded shares of ChinaEdu from a “hold” rating to a “buy” rating in a research note to investors on Tuesday, April 30th. On the ratings front, analysts at Zacks upgraded shares of ChinaEdu from a “neutral” rating to an “outperform” rating in a research note to investors on Tuesday, April 30th. They now have a $6.90 price target on the stock. Finally, analysts at TheStreet downgraded shares of ChinaEdu from a “buy” rating to a “hold” rating in a research note to investors on Monday, April 8th.

Shares of ChinaEdu (NASDAQ: CEDU) traded up 0.17% during mid-day trading on Tuesday, hitting $6.00. ChinaEdu has a one year low of $4.05 and a one year high of $8.36. The stock’s 50-day moving average is currently $6.84. The company has a market cap of $95.4 million and a P/E ratio of 16.69.

ChinaEdu Corporation is an educational service provider in China. The Company’s primary business is to provide services to the online degree programs of Chinese universities.

Mitel Networks (NASDAQ: MITL) traded down 1.29% on Tuesday, hitting $3.84. Mitel Networks has a 52-week low of $2.41 and a 52-week high of $5.01. The stock’s 50-day moving average is currently $3.75. The company has a market cap of $206.1 million and a price-to-earnings ratio of 4.76.

MITL has been the subject of a number of other recent research reports. Analysts at TheStreet upgraded shares of Mitel Networks from a “sell” rating to a “hold” rating in a research note to investors on Wednesday, April 24th. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Mitel Networks in a research note to investors on Friday, April 19th. They now have a $5.00 price target on the stock. Finally, analysts at RBC Capital initiated coverage on shares of Mitel Networks in a research note to investors on Friday, April 19th. They set a “sector perform” rating and a $4.25 price target on the stock.

Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $5.22.

Mitel Networks Corporation is a provider of integrated communications solutions focused on the small-to-medium sized enterprise (NASDAQ: MITL).

The analysts wrote, “in the ph.III endometriosis results (1H14) and the ph.IIb fibroids results (2H14). Given these blockbuster opportunities, we envisage significant upside on positive outcomes. We view secondary asset, NBI-98854, for tardive dyskinesia (TD), as risky, but believe only modest value is baked in.”

Neurocrine Biosciences (NASDAQ: NBIX) traded down 0.16% on Tuesday, hitting $12.70. Neurocrine Biosciences has a 1-year low of $6.25 and a 1-year high of $12.85. The stock’s 50-day moving average is currently $11.57. The company’s market cap is $847.5 million.

Neurocrine Biosciences (NASDAQ: NBIX) last issued its quarterly earnings data on Thursday, May 2nd. The company reported ($0.18) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.18). The company had revenue of $0.70 million for the quarter, compared to the consensus estimate of $1.07 million. During the same quarter last year, the company posted ($0.01) earnings per share. Neurocrine Biosciences’s revenue was down 93.8% compared to the same quarter last year. Analysts expect that Neurocrine Biosciences will post $-0.79 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at TheStreet downgraded shares of Neurocrine Biosciences from a “buy” rating to a “hold” rating in a research note to investors on Tuesday, May 7th. Analysts at Zacks reiterated an “outperform” rating on shares of Neurocrine Biosciences in a research note to investors on Friday, May 3rd. They now have a $14.00 price target on the stock.

One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Neurocrine Biosciences presently has an average rating of “Buy” and a consensus price target of $14.40.

Develops drugs to treat nervous and immune system disorders. The Company researches and develops drugs that treat diseases related to the interaction of the nervous, immune, and endocrine systems in humans, such as anxiety, depression, Alzheimer’s disease, obesity and multiple sclerosis.

Shares of Invesco Mortgage Capital (NYSE: IVR) traded up 2.03% during mid-day trading on Tuesday, hitting $18.60. Invesco Mortgage Capital has a 52 week low of $17.40 and a 52 week high of $22.26. The stock’s 50-day moving average is currently $19.66. The company has a market cap of $2.515 billion and a P/E ratio of 6.49.

Invesco Mortgage Capital (NYSE: IVR) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.02. The company had revenue of $92.91 million for the quarter, compared to the consensus estimate of $93.23 million. During the same quarter in the previous year, the company posted $0.72 earnings per share. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. Analysts expect that Invesco Mortgage Capital will post $2.50 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Ladenburg Thalmann upgraded shares of Invesco Mortgage Capital from a “neutral” rating to a “buy” rating in a research note to investors on Tuesday, May 7th. They now have a $23.00 price target on the stock. They noted that the move was a valuation call. Analysts at Keefe, Bruyette & Woods cut their price target on shares of Invesco Mortgage Capital from $22.00 to $21.50 in a research note to investors on Monday, May 6th. They now have a “market perform” rating on the stock.

Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $21.81.

The company also recently declared a quarterly dividend, which is scheduled for Friday, July 26th. Investors of record on Thursday, June 27th will be given a dividend of $0.65 per share. This represents a $2.60 dividend on an annualized basis and a yield of 14.26%. The ex-dividend date of this dividend is Tuesday, June 25th.

Invesco Mortgage Capital Inc. is a real estate investment trust (NYSE: IVR) primarily focused on investing in, financing and managing residential and commercial mortgage-backed securities and mortgage loans, which it collectively refers to as its target assets.

A number of other firms have also recently commented on MXIM. Analysts at Barclays Capital cut their price target on shares of Maxim Integrated Products from $30.00 to $28.00 in a research note to investors on Tuesday, June 11th. Separately, analysts at Susquehanna downgraded shares of Maxim Integrated Products from a “positive” rating to a “neutral” rating in a research note to investors on Tuesday, June 11th. They now have a $30.00 price target on the stock, down previously from $37.00. Finally, analysts at JP Morgan Cazenove downgraded shares of Maxim Integrated Products from an “overweight” rating to a “neutral” rating in a research note to investors on Monday, June 10th. They now have a $30.00 price target on the stock, down previously from $38.00.

Ten analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $33.52.

Maxim Integrated Products (NASDAQ: MXIM) traded up 0.46% on Tuesday, hitting $28.32. Maxim Integrated Products has a 1-year low of $23.55 and a 1-year high of $33.67. The stock’s 50-day moving average is currently $32.02. The company has a market cap of $8.243 billion and a price-to-earnings ratio of 18.93.

Maxim Integrated Products (NASDAQ: MXIM) last announced its earnings results on Thursday, April 25th. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.41 by $0.04. The company had revenue of $604.90 million for the quarter, compared to the consensus estimate of $596.75 million. During the same quarter last year, the company posted $0.33 earnings per share. Maxim Integrated Products’s revenue was up 5.9% compared to the same quarter last year. Maxim Integrated Products has set its Q4 guidance at $0.45-0.49 EPS. On average, analysts predict that Maxim Integrated Products will post $1.80 earnings per share for the current fiscal year.

Maxim Integrated Products, Inc. (NASDAQ: MXIM), designs, develops, manufactures and markets a range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations.

Several analysts have recently commented on the stock. Analysts at Citigroup upgraded shares of Applied Materials from a “neutral” rating to a “buy” rating in a research note to investors on Wednesday, June 12th. They now have a $20.00 price target on the stock, up previously from $14.00. On a related note, analysts at Deutsche Bank reiterated a “hold” rating on shares of Applied Materials in a research note to investors on Monday, June 3rd. They now have a $15.00 price target on the stock, up previously from $13.00. Finally, analysts at BNP Paribas reiterated an “underperform” rating on shares of Applied Materials in a research note to investors on Monday, June 3rd. They now have a $12.00 price target on the stock.

Five research analysts have rated the stock with a sell rating, seven have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Applied Materials presently has a consensus rating of “Hold” and a consensus price target of $14.79.

Applied Materials (NASDAQ: AMAT) traded up 1.20% on Tuesday, hitting $15.97. Applied Materials has a 1-year low of $9.95 and a 1-year high of $13.99. The stock’s 50-day moving average is currently $13.35. The company’s market cap is $19.190 billion.

Applied Materials (NASDAQ: AMAT) last posted its quarterly earnings results on Thursday, May 16th. The company reported $0.16 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.13 by $0.03. The company had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the prior year, the company posted $0.27 earnings per share. On average, analysts predict that Applied Materials will post $0.64 earnings per share for the current fiscal year.

Applied Materials, Inc. (NASDAQ: AMAT) provides manufacturing equipment, services and software to the global semiconductor, flat panel display, solar photovoltaic (PV) and related industries.

TDSC has been the subject of a number of other recent research reports. Analysts at BB&T raised their price target on shares of 3D Systems to $56.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Piper Jaffray raised their price target on shares of 3D Systems from $42.00 to $52.00 in a research note to investors on Wednesday, May 22nd. They now have an “overweight” rating on the stock. Finally, analysts at Needham & Company raised their price target on shares of 3D Systems from $42.00 to $52.00 in a research note to investors on Monday, May 20th. They now have a “buy” rating on the stock.

One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $54.17.

3D Systems Corporation (NASDAQ: TDSC) is a holding company that operates through subsidiaries in the United States, Europe and the Asia-Pacific region.

A number of other analysts have also recently weighed in on NSU. Analysts at Scotiabank initiated coverage on shares of Nevsun Resources in a research note to investors on Friday. They set an “outperform” rating and a C$5.30 price target on the stock. Separately, analysts at CIBC upgraded shares of Nevsun Resources from an “underperform” rating to a “sector perform” rating in a research note to investors on Tuesday, May 14th. Finally, analysts at Raymond James initiated coverage on shares of Nevsun Resources in a research note to investors on Friday, May 3rd. They set an “outperform” rating and a C$4.50 price target on the stock.

Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of C$4.70.

Shares of Nevsun Resources (TSE: NSU) traded down 3.12% during mid-day trading on Tuesday, hitting $3.11. Nevsun Resources has a 52 week low of $2.75 and a 52 week high of $4.96. The stock’s 50-day moving average is currently $3.65. The company has a market cap of $618.9 million and a P/E ratio of 5.63.

Nevsun Resources Ltd. (TSE: NSU) is a gold and base metal mining and exploration company.